Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: In vitro and in vivo characterization

被引:34
作者
Sandri, G
Bonferoni, MC
Chetoni, P
Rossi, S
Ferrari, F
Ronchi, C
Caramella, C
机构
[1] Univ Pavia, Sch Pharm, Dept Pharmaceut Chem, I-27100 Pavia, Italy
[2] Univ Pisa, Sch Pharm, Dept Bioorgan Chem & Biopharmaceut, I-56100 Pisa, Italy
[3] Monteres SpA, Milan, Italy
关键词
tetrahydrozoline hydrochloride; hyaluronic acid; polyacrylic acid; chitosan; gelatin; mucoadhesion properties; drug release properties; ex vivo/in vivo residence properties; physical stability; steam sterilization;
D O I
10.1016/j.ejpb.2005.07.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim of the work was to develop mucoadhesive eyedrops containing tetrahydrozoline hydrochloride (TZ), a decongestant drug, and based on a ternary interaction drug-polymer-polymer. The anionic polymers assessed were the anionic hyaluronic acid (HA) and polyacrylic acid (PAA), the cationic chitosan (HCS) and the polyelectrolyte gelatin (G). Formulations based on the ternary systems TZ/G/HA, TZ/HCS/HA, TZ/G/PAA and TZ/HCS/PAA at the stoichiometry ratios between cationic and anionic polymers and containing a 10 and 20 fold excess of the anionic polymers were prepared. The formulations were characterized for in vitro mucoadhesive and release properties. The ex vivo/in vivo residence properties were assessed for the formulations that combined the better in vitro mucoadhesive and release properties. The physical stability of the formulations selected was determined following steam sterilization and storage at 25 and 40 degrees C. The synergistic effect of G with HA and PAA improves the mucoadhesion of the formulations while the interaction of HCS with HA and PAA is likely to produce higher neutralization of the anionic polymer charge and minor chain flexibility resulting in a limited mucoadhesion improvement. Both G and HCS participate to control drug release. The selected formulations demonstrate to possess consistency (viscosity) sensitive to the ions of the medium, and probably for this reason the ex vivo/in vivo residence properties could not directly correlated to mucoadhesion and to drug release control properties. However, the formulations are able to maintain levels of TZ detectable until 20 min after the instillation in rabbits, while TZ was not detectable since 3 min after instillation of the drug solution. The physical stability, following steam sterilization and storage, the low viscosity combined with good residence time in conjunctival sac make the TZ/G/20HA the more promising formulation. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:59 / 69
页数:11
相关论文
共 27 条
[1]  
ALBASINI M, 1995, IL FARMACO, V50, P27
[2]   STABILITY-INDICATING DETERMINATION OF TETRAHYDROZOLINE HYDROCHLORIDE IN OPHTHALMIC SOLUTIONS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ANDERMANN, G ;
RICHARD, A .
JOURNAL OF CHROMATOGRAPHY, 1984, 298 (01) :189-192
[3]   Effect of steam sterilization on the rheology of polymer solutions [J].
Bindal, A ;
Narsimhan, G ;
Hem, SL ;
Kulshreshtha, A .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2003, 8 (03) :219-228
[4]   Current therapy of allergic conjunctivitis [J].
Bisca, M .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1997, 58 (11) :828-841
[5]   Characterization of a diltiazem-lambda carrageenan complex [J].
Bonferoni, MC ;
Rossi, S ;
Ferrari, F ;
Bettinetti, GP ;
Caramella, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 200 (02) :207-216
[6]   Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex [J].
Bonferoni, MC ;
Rossi, S ;
Ferrari, F ;
Caramella, C .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2004, 9 (02) :155-162
[7]   Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies [J].
Bonferoni, MC ;
Chetoni, P ;
Giunchedi, P ;
Rossi, S ;
Ferrari, F ;
Burgalassi, S ;
Caramella, C .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (03) :465-472
[8]   A modified Franz diffusion cell for simultaneous assessment of drug release and washability of mucoadhesive gels [J].
Bonferoni, MC ;
Rossi, S ;
Ferrari, F ;
Caramella, C .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 1999, 4 (01) :45-53
[9]  
CARAMELLA C, 1994, EUR J PHARM BIOPHARM, V40, P213
[10]   Optimisation of carbomer viscous eye drops: an in vitro experimental design approach using rheological techniques [J].
Ceulemans, J ;
Ludwig, A .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (01) :41-50